| Value | ₹37.64 Cr |
|---|---|
| Execution period | 4-5 weeks |
BSE filing, NSE: HCG. Summary written from the filing by ALFA Finder's alert engine.
Healthcare Global Enterprises Ltd: key numbers
- Share price
- ₹585.60
- Market cap
- ₹8,743 Cr
- Revenue (annual)
- ₹2,545 Cr
- Net profit (annual)
- ₹13.76 Cr
- P/E (TTM)
- 383.5×Sector 52.0×
- Promoter holding
- 64.21%+0.00% QoQ
- FII holding
- 2.70%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Healthcare Global Enterprises Ltd
All →Healthcare Global Enterprises Other Announcement
HealthCare Global Enterprises Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Healthcare Global Enterprises Board Meeting Date
HealthCare Global Enterprises will hold a board meeting on November 05, 2026, to consider and approve the unaudited financial results for the quarter ended September 30, 2026.
Healthcare Global Enterprises Acquisition Worth ₹0 Cr
Healthcare Global's subsidiary, HCG Kenya, increased its stake in Advanced Molecular Imaging Limited (AMIL) to 50.10% by acquiring additional shares for approximately ₹0.003 Crore.
- Value
- ₹0.00 Cr
Healthcare Global Enterprises Other Announcement
The company clarified discrepancies in shareholding pattern filings, attributing differences to the timing of corporate actions following a rights issue and NDU disclosure variances.
Healthcare Global Enterprises Acquisition
Healthcare Global's subsidiary acquired an additional 0.10% stake in Advanced Molecular Imaging Limited for INR 0.00 Crore, making it a subsidiary of the company.
Healthcare Global Enterprises Other Announcement
Designated person Ashwini P Kavadimatti disclosed a pledge creation of 5,000 shares and a market sale of 500 shares of HealthCare Global Enterprises Ltd.
- Value
- ₹0.38 Cr
Other merger & restructuring announcements
All →Quint Digital Merger & Restructuring
Quint Digital's board approved a Rule 10b5-1 trading plan and the incorporation of a wholly owned overseas subsidiary. No investment amount was disclosed.
Hexaware Technologies Merger & Restructuring
Hexaware Technologies approved a slump sale of its step-down subsidiary Tech SMC Square India to Tech SMC Squared (GCC) India, a related-party deal. Consideration is cash, yet to be set by a registered valuer.
- Execution
- Expected completion by 30 June 2027; agreement date stated as 1 December 2026
Emkay Global Financial Services Merger & Restructuring Worth ₹2.75 Cr
Emkay Global agreed to sell its Wealth Management Business to a step-down subsidiary, Emkay Wealth Advisory, for Rs. 2.75 Crore cash. Completion is expected by 26 January 2027.
- Value
- ₹2.75 Cr
- Execution
- Completion expected by 26 January 2027
TVS Holdings Merger & Restructuring
TVS Holdings forwarded TVS Motor's board outcome of October 28, 2026 approving acquisition of Harita ARC and a composite scheme of amalgamation and demerger. The scheme is subject to stock exchange, SEBI, NCLT and shareholder approvals.
Emkay Global Financial Services Merger & Restructuring Worth ₹30 Cr
Emkay Global approved transferring two subsidiaries to new subsidiary ECPL and slump-selling its wealth business. Up to Rs.30 Crore rights investment in ECPL was also approved.
- Value
- ₹30.00 Cr
- Execution
- Divestment completion expected within 90 days of SPA execution, subject to regulatory approvals
Fortis Healthcare Merger & Restructuring Worth ₹277 Cr
Fortis subsidiary International Hospital acquired Suguna Ramaiah Hospitals' business, operations, land and building for Rs 277 Crore cash. The deal was consummated today, strengthening Bengaluru presence.
- Value
- ₹277.0 Cr